ID: ALA5280383

Max Phase: Preclinical

Molecular Formula: C30H30BrFN2O

Molecular Weight: 453.58

Associated Items:

Representations

Canonical SMILES:  CCCCn1c2cc(OCc3ccc(F)cc3)ccc2c2cc[n+](Cc3ccccc3)c(C)c21.[Br-]

Standard InChI:  InChI=1S/C30H30FN2O.BrH/c1-3-4-17-33-29-19-26(34-21-24-10-12-25(31)13-11-24)14-15-27(29)28-16-18-32(22(2)30(28)33)20-23-8-6-5-7-9-23;/h5-16,18-19H,3-4,17,20-21H2,1-2H3;1H/q+1;/p-1

Standard InChI Key:  JGWBVGJOVYUQAZ-UHFFFAOYSA-M

Associated Targets(Human)

Serine/threonine-protein kinase PLK1 28605 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serine/threonine-protein kinase PLK2 1028 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serine/threonine-protein kinase PLK3 1916 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 453.58Molecular Weight (Monoisotopic): 453.2337AlogP: 6.96#Rotatable Bonds: 8
Polar Surface Area: 18.04Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 2.58CX LogD: 2.58
Aromatic Rings: 5Heavy Atoms: 34QED Weighted: 0.23Np Likeness Score: -0.50

References

1. Luo B, Song X..  (2021)  A comprehensive overview of β-carbolines and its derivatives as anticancer agents.,  224  [PMID:34332400] [10.1016/j.ejmech.2021.113688]

Source